cholesterol-lowering drug therapy almost pays for itself

June 1996

Lately we've seen lots of reports about cholesterol-lowering therapy reducing the risk of heart disease and saving lives.

Now a new analysis in the journal Circulation suggests that cholesterol-lowering drug therapy almost pays for itself...with savings in hospital costs.

Statins can cost about $2 a day...but that's lowered to just 28 cents a day when the savings are taken into account.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

three new HIV tests
Obesity & Weight Loss safety of the popular new diet pill, Redux (dexfenfluramine)
Serzone (nefazodone) may cause less sexual dysfunction than SSRIs
Paxil (paroxetine) for panic disorder and obsessive compulsive disorder (OCD)
Multiple Sclerosis Avonex (interferon beta-1a), the new treatment for multiple sclerosis (MS)
Dermatology Lamisil (terbinafine) TABLETS for treating fungal nail infections
Infectious Diseases new 3-day Cipro Cystitis Pack
Infectious Diseases Bactroban Nasal (mupirocin ointment) to reduce the spread of MRSA
Infectious Diseases Maxipime (MAXI-peem, cefepime), the first "fourth-generation" injectable cephalosporin
Cholesterol cholesterol-lowering drug therapy almost pays for itself
patient compliance for their new protease inhibitor, Norvir (ritonavir)
ACE Inhibitors ACE inhibitors for renal disease
ACE Inhibitors new ACE inhibitor, Mavik (trandolapril)
estrogen for postpartum depression

cholesterol-lowering drug therapy almost pays for itself

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents